Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiangyue https://orcid.org/0000-0003-0716-6815
McGinnis, Christopher S.
Yu, Guotao https://orcid.org/0000-0002-7430-3309
Chen, Sijie https://orcid.org/0000-0003-4331-0773
Zheng, Pingping
Schürch, Christian M. https://orcid.org/0000-0002-1792-1768
Hiam-Galvez, Kamir J.
Reticker-Flynn, Nathan E. https://orcid.org/0000-0002-9963-039X
Guo, Wenhui
Yao, Winnie https://orcid.org/0000-0003-1159-5153
Qiu, Jingtao https://orcid.org/0000-0003-0354-8357
Muselman, Alexander https://orcid.org/0000-0002-5685-2646
Linde, Ian L. https://orcid.org/0000-0002-6077-7466
Hickey, John W.
Yan, Hao
Tran, Victoria M.
Qiu, Wenli
Brichart-Vernos, Delphine
Hirai, Toshihito
Yu, Bo
An, Xiuli
Xiao, Yanling https://orcid.org/0000-0003-1755-1709
Paidassi, Helena https://orcid.org/0000-0001-9915-4365
Scharschmidt, Tiffany C.
Angelo, Michael https://orcid.org/0000-0003-1531-5067
Sheppard, Dean https://orcid.org/0000-0002-6277-2036
Chi, Hongbo https://orcid.org/0000-0002-9997-2496
Satpathy, Ansuman T. https://orcid.org/0000-0002-5167-537X
Way, Sing Sing https://orcid.org/0000-0001-8948-1952
Malissen, Bernard https://orcid.org/0000-0003-1340-9342
Strober, Samuel
Engleman, Edgar G. https://orcid.org/0000-0002-2096-9279
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 28 October 2025
First Online: 10 December 2025
Competing interests
: X.Z. is a cofounder and shareholder of ImmunEdge Inc. E.G.E. is a founder, shareholder and board member of ImmunEdge Inc. B.Y. is a shareholder of ImmunEdge Inc. X.Z and E.G.E. are Stanford-affiliated inventors of PCT/US2023/063997, entitled ‘Epo Receptor Agonists and Antagonists’. C.S.M. holds patents related to MULTI-seq. C.M.S. is a cofounder and scientific advisor of Vicinity Bio GmbH and is on the scientific advisory board of and has received research funding from Enable Medicine Inc., all outside the current work. T.C.S. is a scientific advisory board member for Concerto Biosciences. M.A. is a consultant, board member, and shareholder in Ionpath Inc. D.S. is a founder of Pliant Therapeutics and Glial Biosciences and is on the Genentech Scientific Review Board and the Amgen Inflammation Scientific Review Board, and an advisor to Lila Biologics, Arda Therapeutics and TCGFB Inc. H.C. is a consultant for Kumquat Biosciences and TCura Bioscience. A.T.S. is a founder of Immunai, Cartography Biosciences and Prox Biosciences, an advisor to Zafrens and Wing Venture Capital, and receives research funding from Merck Research Laboratories. The other authors declare no competing interests.
